Immunotherapy has become one of the most strategically important pillars in modern biotechnology. Over the past decade, US biotech firms have rapidly expanded their immunotherapy pipelines as advances in tumor immunology, cellular engineering, and biomarker science reshape how diseases are treated. What began largely as an oncology breakthrough has evolved into a broad therapeutic platform … Read more
Microfluidics technology is rapidly reshaping the way pharmaceutical companies approach drug research and development. By manipulating tiny volumes of fluids in microscale channels, researchers can recreate complex biological environments with exceptional precision. This capability is allowing biotechnology firms and research institutions to accelerate screening, reduce reagent use, and generate higher-quality experimental data. In the United … Read more
The role of nanotechnology in modern healthcare is expanding rapidly across drug delivery, diagnostics, imaging, and regenerative medicine. As materials engineering converges with molecular biology, nanoscale platforms are enabling targeted therapies and precision diagnostics that align with the evolving standards of US regulatory oversight and value-based care. For biotechnology companies and healthcare investors, nanotechnology is … Read more